Caveolin‑1 is a membrane-associated protein expressed in many cell types that plays a key role in modulating inflammatory ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions for two biosimilars that could expand access for clinicians treating retinal ...

Researchers have developed an injectable inflammation-responsive hydrogel (IRH), which tests in mice showed can deliver an anti-inflammatory drug directly to the retina of the eye. Reporting on in ...

A real-world safety study found that patients treated with brolucizumab had low occurrences of intraocular inflammation, retinal vascular occlusion, and retinal vasculitis. A study published in ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

Tuberculosis, or TB, is often associated with the lungs, but it can also affect other parts of your body, including the eyes. A new study has raised concern that eye tuberculosis (ocular TB) may ...

Chronic inflammation has been one of the most heavily researched topics in the health world in recent years, with doctors ...

There are two types of inflammation: acute and chronic. Acute inflammation is the kind that lasts a few hours, days, or weeks, and it’s helpful to healing. It’s your immune system’s response when ...